Adaptive laboratory evolution boosts formate-based growth in acetogen Clostridium sp. AWRP

Bacteria that can eat one of the simplest carbon molecules on Earth—formate—and turn it into useful chemicals have long been touted as a cornerstone of tomorrow’s sustainable biomanufacturing. Now, researchers in South Korea have taken a major step toward making that vision practical. By patiently coaxing a gas-fermenting bacterium to tolerate and thrive on formate through adaptive laboratory evolution, a team at the Korea Institute of Ocean Science and Technology (KIOST) has produced a strain with dramatically improved growth on this single-carbon feedstock, and they have mapped, at the level of genes and mutations, exactly how the microbe rewired its metabolism to pull it off. The work, published in Biotechnology for Biofuels and Bioproducts, offers a molecular blueprint for engineering formate-based microbial cell factories that could one day convert captured carbon dioxide or industrial off-gases into acetate, ethanol, and other value-added products without relying on sugar crops or petroleum.

The organism at the heart of the study is Clostridium sp. AWRP, an acetogen—a class of anaerobic bacteria distinguished by their possession of the Wood–Ljungdahl pathway, an ancient metabolic route that allows them to fix carbon dioxide, carbon monoxide, or formate and funnel it into central metabolism. Acetogens are prized industrially because they can grow on synthesis gas from steel mills or on electrochemically reduced CO2, making them attractive chassis for carbon-negative bioproduction. Formate is an especially appealing feedstock: it is a liquid at ambient conditions, it is non-volatile and relatively safe to handle, and it can be produced electrochemically from CO2 using renewable electricity. In effect, formate is a chemical battery for carbon and energy, ready to be discharged into living cells. The theoretical appeal is enormous—if microbes can be taught to consume formate efficiently, renewable electricity could be translated directly into biomass and bio-products.

There was, however, a catch. When the KIOST team first examined Clostridium sp. AWRP, they found that the bacterium carries not one but three distinct formate dehydrogenases—the enzymes that oxidize formate and pass its electrons into the cell’s energy-conserving machinery. On paper, AWRP should have been a capable formate consumer. In practice, the wild-type strain stalled badly: whenever formate was supplied as a growth substrate, cells entered an extended lag phase before growth even began. The culprit is formate toxicity. At the concentrations needed to sustain meaningful production, formic acid is a weak acid that can cross cellular membranes in its undissociated form, dissociate inside the relatively neutral cytoplasm, and release a proton burden that the cell must spend energy to expel. The anion itself also interferes with metabolic flux. For AWRP, formate was less a feast than a slow poison—at least initially.

To overcome this bottleneck, the researchers turned to adaptive laboratory evolution, a technique that harnesses natural selection rather than rational genetic engineering. Cultures of AWRP were grown over serial transfers in media containing progressively challenging levels of formate, allowing the population to accumulate and enrich for spontaneous mutations that improve tolerance and utilization. Over the course of this evolutionary experiment, a single lineage emerged that the team designated F30T—a strain capable of tolerating formate concentrations of up to 300 millimolar, a level that would severely inhibit the ancestor. Crucially, the adapted strain did not merely survive formate; it grew on it with a markedly accelerated growth rate and a shortened lag phase, transforming formate from a stressor into a genuine substrate.

The real surprise came when the researchers sequenced the genomes and transcriptomes of the evolved strain. Whole-genome comparison between F30T and the wild type revealed six key non-synonymous mutations—single DNA changes that alter the amino acid sequence of the encoded proteins. Among the affected genes were ackA, which encodes acetate kinase, the enzyme catalyzing the final step of acetate production and substrate-level phosphorylation, and adhE1, the bifunctional aldehyde–alcohol dehydrogenase that governs ethanol formation and redox balance in clostridia. That mutations landed precisely on the enzymatic levers of AWRP’s fermentation network suggests that evolution fine-tuned the bacterium’s product spectrum and energy yield to better suit a formate-driven economy. Mutations in regulatory or other metabolic genes likely compounded these effects, coordinating a system-wide shift rather than a single enzyme tweak.

Transcriptomic profiling made the depth of that shift vivid. Under formate-supplemented conditions, F30T differentially expressed 948 genes out of a total genome of 4,199—nearly a quarter of its entire genetic repertoire. The pattern of expression changes revealed what the authors describe as a sophisticated, multi-layered strategy for coping with organic acid stress while squeezing every joule of energy from a thermodynamically meager substrate. At the core of the stress response was pH management. Formate influx threatens to acidify the cytoplasm, so F30T ramped up three interlocking buffering systems: the arginine deiminase pathway, which catabolizes arginine while consuming a proton and generating ATP; histidine biosynthesis, whose nitrogen-rich intermediates help maintain intracellular pH homeostasis; and ethanolamine utilization, a route that provides both nitrogen metabolism support and additional energy conservation. Together, these pathways act as a chemical sponge for intracellular protons while contributing supplemental ATP—an elegant case of solving two problems with one metabolic stroke.

Equally striking is how stingy the evolved strain became with its energy budget. Growth on formate via the Wood–Ljungdahl pathway operates near the thermodynamic limit of life: the energy released per mole of substrate is among the smallest of any known metabolism, leaving almost no margin for waste. F30T responded with a stringent energy-saving program, downregulating both the F₀F₁-type ATP synthase—the enzyme complex that normally synthesizes or hydrolyzes ATP to manage the proton motive force—and the methyl branch of the Wood–Ljungdahl pathway itself. Dialing back these energy-hungry components appears to reduce futile cycling and preserve the scarce proton gradient for essential work. At the same time, the strain bolstered its physical resilience by upregulating molecular chaperones, the protein-folding first responders that shield cellular machinery from acid-induced damage. The net result is a cell that spends less, buffers more, and repairs faster.

The proof of concept came in bioreactor experiments. Using a pH-stat fed-batch system fed with formic acid—a configuration that allows continuous substrate delivery while automatically neutralizing acidification—the F30T strain achieved a higher biomass yield than the wild type while matching its ancestor’s acetate yield from formate. In industrial terms, that means the evolved strain converts more of the feedstock into cells, the raw material for further engineering toward any desired product, without sacrificing the core chemical output. For a metabolism as energy-constrained as acetogenesis, that improvement is not trivial; it reflects a genuinely rebalanced metabolic network, not a cosmetic gain in tolerance.

The significance of the study lies as much in its systems-level analysis as in the strain itself. By coupling adaptive laboratory evolution with whole-genome sequencing and RNA-seq, the researchers illuminated the molecular logic of formate tolerance: which mutations matter, which pathways absorb the proton stress, which energy-saving circuits throttle back, and which protective proteins surge forward. This mechanistic map transforms what could have been a black-box evolutionary experiment into a set of actionable engineering targets. Synthetic biologists seeking to build formate-based production strains can now borrow the arginine deiminase pathway as a pH buffer, tune acetate kinase to redirect flux, or relax ATP synthase expression to conserve energy—rationally rather than waiting for evolution to stumble upon solutions.

The broader context is the fast-growing field of C1 bioproduction, in which single-carbon molecules—CO2, CO, methane, methanol, and formate—serve as feedstocks for fermentation. Formate occupies a privileged position in this landscape because it bridges electrochemistry and biology: renewable electricity can reduce CO2 to formate at high efficiency, and formate can then be delivered to microbes without the gas-transfer limitations that hamper syngas fermentation. Acetogens like Clostridium sp. AWRP, once made formate-tolerant and formate-proficient, become the metabolic interface between the electric grid and the chemical industry. The KIOST work, supported by the institute’s in-house programs, demonstrates that the tolerance barrier—long a practical roadblock—can be dismantled through evolution and understood through genomics.

Challenges remain before formate-fed bioreactors become commercially routine. Laboratory evolution optimizes for growth, not necessarily for titer, rate, and yield of a target product, and further engineering will be needed to redirect the improved formate flux toward fuels and chemicals beyond acetate. Scale-up will demand careful control of pH, formate concentration, and redox balance. Yet the F30T strain and its molecular characterization represent a genuine advance: they show that one of anaerobic biotechnology’s most energy-frugal catalysts can be reprogrammed, through a combination of a handful of mutations and massive coordinated gene-expression changes, to flourish on a feedstock derived from captured carbon. As the search intensifies for routes that convert renewable power into storable, shippable carbon products, evolved acetogens like F30T may well become a foundational platform—living bridges between electricity and the molecules of modern industry.